Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 6

What is the future and impact of artificial intelligence and machine learning (AI/ML) in each SIGs

Panel Discussion

Wednesday, November 13, 2024
10:00 AM – 10:30 AM MST
Location: Canyon Ballroom

    Panelist(s)

  • Hao Zhu, PhD

    ISoP Board Member
    ISoP, Maryland, United States

    Disclosure(s): No financial relationships to disclose

  • Hao-Jie Zhu, PhD

    Professor
    University of Michigan College of Pharmacy

    Disclosure(s): No financial relationships to disclose

  • Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers)

    Platform Scientific Lead
    Pharmetheus

    Disclosure(s): GSK: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Yuan Xiong, PhD

    Director
    Johnson & Johnson

    Disclosure(s): No financial relationships to disclose

  • NT

    Neelima Thanneer, MS

    Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting
    BMS, United States

    Disclosure(s): No financial relationships to disclose

  • Jiawei Zhou, PhD (she/her/hers)

    Manager, Pharmacometrics & Systems Pharmacology
    Pfizer, Inc.
    Greenville, South Carolina, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Hao Zhu, PhD: No financial relationships to disclose
Hao-Jie Zhu, PhD: No financial relationships to disclose
Lourdes Cucurull-Sanchez, PhD MPhil: GSK: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Yuan Xiong, PhD: No financial relationships to disclose
Neelima Thanneer, MS: No financial relationships to disclose
Limei Cheng, PhD: Incyte Corporation: Employment (Ongoing)